Dow Down 1.40% Nasdaq Down 1.59%

AbbVie Inc. (ABBV)

-NYQ
57.23 Down 0.53(0.92%) 4:00PM EDT
|After Hours : 57.40 Up 0.17 (0.30%) 4:30PM EDT
Prev Close:57.76
Open:57.93
Bid:56.98 x 100
Ask:59.47 x 100
1y Target Est:67.38
Beta:1.928
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:56.96 - 57.94
52wk Range:44.32 - 60.02
Volume:8,431,876
Avg Vol (3m):12,196,400
Market Cap:91.09B
P/E (ttm):22.18
EPS (ttm):2.58
Div & Yield:1.68 (3.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.92%91.09B
MRKDown 0.96%169.36B
NVSDown 0.97%226.17B
PFEDown 1.42%184.84B

Key Statistics

Forward P/E (1 yr):14.67
P/S (ttm):4.77
Ex-Dividend Date:11-Jul-14

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback